Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation [Phase 4]

View source ↗

Summary

A completed Phase 4 trial comparing Advagraf (tacrolimus extended-release) with Prograf (tacrolimus) in de novo kidney transplant recipients one month after tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: de Novo Kidney Transplantation | Phase 4 | Status: COMPLETED